Cargando…

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial

BACKGROUND: The chronic and progressive nature of chronic obstructive pulmonary disease (COPD) requires self-administration of inhaled medication. Dry powder inhalers (DPIs) are increasingly being used for inhalation therapy in COPD. Important considerations when selecting DPIs include inhalation ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altman, Pablo, Wehbe, Luis, Dederichs, Juergen, Guerin, Tadhg, Ament, Brian, Moronta, Miguel Cardenas, Pino, Andrea Valeria, Goyal, Pankaj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001060/ https://www.ncbi.nlm.nih.gov/pubmed/29898702 http://dx.doi.org/10.1186/s12890-018-0662-0

Ejemplares similares

Tiotropium HandiHaler(®) in the treatment of COPD: A safety review
por: Kesten, Steven, et al.
Publicado: (2009)

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis
por: Halpin, David MG, et al.
Publicado: (2015)

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)
por: Dekhuijzen, Pieter Nicolaas Richard, et al.
Publicado: (2016)

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial
por: Dahl, Ronald, et al.
Publicado: (2015)

Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2016)

Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study
por: Trotta, Francesco, et al.
Publicado: (2017)

A dose-ranging study of tiotropium delivered via Respimat(®) Soft Mist(TM) Inhaler or HandiHaler(®) in COPD patients
por: Caillaud, Denis, et al.
Publicado: (2007)

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®
por: Ohar, Jill A., et al.
Publicado: (2020)

Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies
por: ZuWallack, Richard, et al.
Publicado: (2014)

Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial
por: Wise, Robert, et al.
Publicado: (2015)

A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?
por: Dahl, Ronald, et al.
Publicado: (2016)

Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch
por: Hanada, Soichiro, et al.
Publicado: (2015)

Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair(®) versus HandiHaler(®) in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial
por: Yildiz, Pinar, et al.
Publicado: (2016)

Performance Characteristics of Breezhaler(®) and Aerolizer(®) in the Real-World Setting
por: Molimard, Mathieu, et al.
Publicado: (2021)

The evaluation of the correct use and ease‐of use of the ELLIPTA DPI in children with asthma
por: Halverson, Philip, et al.
Publicado: (2020)

Washington R. Handy
Publicado: (1858)

Handy Method for Hypodermy
Publicado: (1873)

Computerist's handy databook : dictionary
por: Hallmark, Clayton L.
Publicado: (1979)

Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD
por: Represas-Represas, Cristina, et al.
Publicado: (2020)

Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume
por: Haikarainen, Jussi, et al.
Publicado: (2020)

Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study
por: Pascual, Sergi, et al.
Publicado: (2015)

The handy astronomy answer book
por: Liu, PhD, Charles
Publicado: (2013)

The handy math answer book
por: Barnes-Svarney, Patricia, et al.
Publicado: (2012)

The handy physics answer book
por: Liu, Charles
Publicado: (2020)

A Handy Book of Meteorology
Publicado: (1868)

A Handy Electric Light
por: Frantz, L. O.
Publicado: (1904)

The Medical Man's Handy Book
Publicado: (1883)

Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler(®) Device in Patients with Asthma
por: Bartels, Christian, et al.
Publicado: (2021)

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD
por: Ghosh, Sohini, et al.
Publicado: (2019)

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
por: Ohar, Jill A, et al.
Publicado: (2022)

Effect of the Inspiratory Method and Timing of Voluntary Cough on Peak Cough Flow
por: Kotajima, Fumiya, et al.
Publicado: (2023)

Handy tool for high-resolution microscopy
por: Williams, Ruth
Publicado: (2006)

Wild Gorillas Handy with a Stick
Publicado: (2005)

A Handy Method of Sterilising Instruments
Publicado: (1902)

Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019)

Evaluating peak inspiratory pressures and tidal volume in premature neonates on NAVA ventilation
por: Protain, Alison P., et al.
Publicado: (2020)

Peak Nasal Inspiratory Flow Evaluation as an objective method of measuring nasal airflow
por: Teixeira, Rodrigo Ubiratan Franco, et al.
Publicado: (2015)

Evaluation of Peak Inspiratory Flow Rate in Hospitalized Palliative Care Patients with COPD
por: Borris, Joshua, et al.
Publicado: (2023)

Medication Adherence and Asthma Control with Once-Daily Indacaterol/Glycopyrronium/Mometasone Furoate Breezhaler Digital Companion: 90-Day Analysis from Germany
por: Woehrle, Holger, et al.
Publicado: (2023)

Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
por: Svedsater, Henrik, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_74r5flllrvb75cploqpafaij1r